Article Text
Leading article
Peginterferon therapy for chronic hepatitis B: one size fits all?
Statistics from Altmetric.com
Footnotes
-
Competing interests HLY Chan is a consultant and has received honorarium for lectures from Abbott, Bristol Myers Squibb, Gilead, Merck, Novartis Pharmaceutical and Roche, and has received an unrestricted grant from Roche for hepatitis B virus research.
-
Provenance and peer review Commissioned; internally peer reviewed.